About the Company
We do not have any company description for Cogent Biosciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $COGT News
Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor
WALTHAM, Mass. and BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a ...
Buy Rating Affirmed for Mirum Pharmaceuticals Amid Positive Clinical Trial Outlook
Citi analyst David Lebovitz has maintained their bullish stance on MIRM stock, giving a Buy rating on April 8. David Lebovitz has given his ...
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session U.S. stock ...
Economic developers brand Lansing as key leg of Michigan’s ‘Research Triangle’
A consortium of groups has set out to brand Lansing as a bioscience destination in a move to better position the region ...
Loading the latest forecasts...